A Platinum Remembrance: The Power of Raising Your Voice
From the article: Advocacy Can Make a Difference Few are aware that, because symptoms typically do not present until the…
AACR Highlights: Monday, September 9
The final plenary sessions of AACR pancreatic cancer conference focused on disease models and how cancer metabolizes energy.
AACR Highlights: Sunday, September 8
Read the highlights of Sunday's sessions about early-stage clinical trials, oncogenes, and early detection at the AACR pancreatic cancer conference.
AACR Highlights: Saturday, September 7
Read the highlights of Saturday's sessions about tumor microenvironment, recurrence, and treatment resistance, at the AACR pancreatic cancer conference.
Let’s Win and Lustgarten to Provide Daily Updates from Pancreatic Cancer Conference
Let’s Win and the Lustgarten Foundation will be providing brief highlights of the AACR pancreatic cancer conference in Boston from September 6-9, 2019.
Lustgarten Foundation In the News
Exciting news from the Lustgarten Foundation, including research discoveries, honors, and a donation from Jeopardy! champ James Holzhauer.
Let’s Win! Pancreatic Cancer Updates Clinical Trials Section
Let's Win announces updates to its clinical trials section on its website. These include a new clinical trial finder, animations,and educational pages.
New Lustgarten-Funded Research Develops Artificial Intelligence Methods to Detect Pancreatic Cancer Earlier
The Lustgarten Foundation funded research into using artificial intelligence to help detect pancreatic cancer earlier in scans.
Journal of Clinical Pathways Podcast 10: Advances in Pancreatic Cancer With Anirban Maitra
Let's Win Scientific Advisory Board member Anirban Maitra discusses pancreatic cancer advances in a podcast sponsored by the Journal of Clinical Pathways.
Key Protein A Possible New Target in the Treatment of Pancreatic Cancer Pancreatic Cancer Collective Supports Important Study Published in Nature
Research supported by the Pancreatic Cancer Collective has found that a key protein may be a new target for developing a new pancreatic cancer treatment.
